CBD Science looks to raise £2M in Series A to advance its plant-based cannabinoid therapy in the UK

CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group’s Series A funding round, on the …

Be the first to comment

Leave a Reply

Your email address will not be published.